The AI drug revolution is real but the hype around it isn’t

This article highlights how AI is beginning to address critical bottlenecks in pharmaceutical development, offering promising advancements despite overly optimistic timelines. For the tech industry and consumers, this signals a transformative shift in how drugs are discovered and brought to market, potentially accelerating access to new treatments. However, it also underscores the importance of managing expectations around AI's current capabilities in healthcare innovation.

• AI is quietly transforming drug discovery processes.
• The timeline for AI-driven health solutions remains optimistic but uncertain.
• Managing expectations is crucial as AI begins to break pharma's biggest bottlenecks.